CSFZX
Price
$59.50
Change
-$0.02 (-0.03%)
Updated
Aug 21 closing price
Net Assets
2.38B
FIKLX
Price
$10.30
Change
-$0.00 (-0.00%)
Updated
Aug 20 closing price
Net Assets
323.3M
Interact to see
Advertisement

CSFZX vs FIKLX

CSFZX vs FIKLX Comparison Chart in %
View a ticker or compare two or three
VS
CSFZX vs. FIKLX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSFZX is a Hold and FIKLX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSFZX has more cash in the bank: 2.38B vs. FIKLX (323M). CSFZX (3.16) and FIKLX (3.13) have matching dividends . CSFZX was incepted earlier than FIKLX: CSFZX (12 years) vs FIKLX (8 years). CSFZX (0.84) is less costly to investors than FIKLX (0.78). FIKLX is a more actively managed with annual turnover of: 77.00 vs. CSFZX (57.00). CSFZX (0) and FIKLX (0) have matching initial minimum investment requirements. CSFZX annual gain was more profitable for investors over the last year : 12.41 vs. FIKLX (0.70). CSFZX return over 5 years is better than : 8.45 vs. FIKLX (-21.51).
CSFZXFIKLXCSFZX / FIKLX
Total Expense Ratio0.840.78108%
Annual Report Gross Expense Ratio0.840.78108%
Fund Existence12 years8 years-
Gain YTD10.660-1.905-560%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.38B323M736%
Annual Yield % from dividends3.163.13101%
Returns for 1 year12.410.701,781%
Returns for 3 years36.5919.73185%
Returns for 5 years8.45-21.51-39%
Returns for 10 years49.22N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PJP130.031.14
+0.89%
Invesco Pharmaceuticals ETF
CALF57.800.50
+0.87%
Pacer US Small Cap Cash Cows 100 ETF
SEMI37.89N/A
+0.01%
Columbia Select Technology ETF
ANV25.39-0.07
-0.27%
GraniteShares Autocallable NVDA ETF
CEE20.49-0.17
-0.82%
Central and Eastern Europe Fund (The)